跳转至内容
Merck
CN

SAB2702215

抗-链球菌标签单克隆抗体 小鼠抗

clone GT517, affinity isolated antibody

别名:

Strep Tag检测抗体, 小鼠Anti-Strep Tag抗体

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

NACRES:
NA.43
UNSPSC Code:
12352203
Conjugate:
unconjugated
Clone:
GT517, monoclonal
Application:
IF, WB
Citations:
8
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


biological source

mouse

Quality Level

conjugate

unconjugated

antibody form

affinity isolated antibody

antibody product type

primary antibodies

clone

GT517, monoclonal

form

buffered aqueous solution

concentration

1mg/mL

technique(s)

indirect immunofluorescence: suitable, western blot: 1000-10000

isotype

IgG1

shipped in

wet ice

storage temp.

−20°C

target post-translational modification

unmodified

General description

strep-标签/strep-标签II(改进版本)由八个氨基酸序列(Trp-Ser-His-Pro-Gln-Phe-Glu-Lys)组成。

Immunogen

用于生成该抗体的免疫原对应于链球菌标签

Application

建议的起始稀释度如下:ICC/IF:1:100-1:1000,蛋白质印迹:1:1000-1:10000.尚未在其他应用中测试。最佳工作稀释度应由最终用户通过实验确定。

Biochem/physiol Actions

strep-标签/strep-标签II(改进版本)具有与任何目标蛋白或肽结合的能力。

Features and Benefits

完放心地使用我们的抗体。如果抗体在您的申请的研究中不起作用,我们将全额退款或安排替代抗体。了解更多信息。

Physical form

磷酸盐缓冲液,未加保护剂。

Other Notes

纯化方法:Protein G亲和纯化

Disclaimer

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。


Still not finding the right product?

或者

试用我们的 产品选型工具 工具缩小选择范围


存储类别

12 - Non Combustible Liquids

wgk

nwg

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

常规特殊物品
低风险生物材料

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Zhaofeng Yan et al.
Nature communications, 11(1), 241-241 (2020-01-15)
A major component of bacterial biofilms is curli amyloid fibrils secreted by the curli biogenesis system. Understanding the curli biogenesis mechanism is critical for developing therapeutic agents for biofilm-related infections. Here we report a systematic study of the curli biogenesis
The Strep-tag system for one-step purification and high-affinity detection or capturing of proteins.
Schmidt TG and Skerra A
Nature Protocols, 2(6), 1528-1528 (2007)
Timothy A Bates et al.
bioRxiv : the preprint server for biology (2020-08-09)
There is currently a lack of biological tools to study the replication cycle and pathogenesis of SARS-CoV-2, the etiological agent of COVID-19. Repurposing the existing tools, including antibodies of SARS-CoV, is an effective way to accelerate the development of therapeutics



全球贸易项目编号

货号GTIN
SAB2702215-100UL04061837274619